Related Experiment Video
Updated: Aug 9, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines
Stefania Pizzimenti1, Federica Briatore, Stefano Laurora
1Section of General Pathology, Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello 30, 10125 Turin, Italy. stefani.pizzimenti@unito.it
4-Hydroxynonenal (HNE) inhibits telomerase activity and human telomerase reverse transcriptase (hTERT) expression in leukemia cells. This occurs by decreasing hTERT promoter activity through modulation of c-Myc and Mad-1 transcription factors.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Oxidative stress produces 4-hydroxynonenal (HNE), which has antiproliferative effects on tumor cells.
- Oxidative stress accelerates telomere loss, impacting cell aging and cancer progression.
- Telomere length is regulated by telomerase activity, with human telomerase reverse transcriptase (hTERT) often upregulated in cancers.
Purpose of the Study:
- To investigate the inhibitory effect of HNE on telomerase activity and hTERT expression in human leukemia cell lines.
- To elucidate the molecular mechanisms underlying HNE-induced hTERT downregulation.
- To examine the role of transcription factors c-Myc, Mad-1, Sp-1, and p53 in mediating HNE's effects.
Main Methods:
- Treatment of human leukemia cell lines (HL-60, U937, ML-1) with HNE.
- Analysis of telomerase activity and hTERT expression.
- Study of transcription factor expression (c-Myc, Mad-1, Sp-1, p53) and DNA binding activity to the hTERT promoter.
Main Results:
- HNE inhibited telomerase activity and hTERT expression in all tested leukemia cell lines.
- HNE modulated transcription factor expression: c-Myc was inhibited, Mad-1 was upregulated, and Sp-1 was unaffected.
- In p53 wild-type ML-1 cells, HNE upregulated p53 expression. In HL-60 cells, HNE altered c-Myc and Mad-1 DNA binding to the hTERT promoter.
Conclusions:
- HNE inhibits telomerase activity in human leukemia cells by decreasing hTERT promoter activity.
- The mechanism involves the modulation of c-Myc and Mad-1 transcription factor expression and activity.
- HNE represents a potential therapeutic agent targeting telomerase in leukemia.
Related Concept Videos
Telomeres and Telomerase
Replicative Cell Senescence

